CN103181025A - 丝电子部件 - Google Patents
丝电子部件 Download PDFInfo
- Publication number
- CN103181025A CN103181025A CN2011800288738A CN201180028873A CN103181025A CN 103181025 A CN103181025 A CN 103181025A CN 2011800288738 A CN2011800288738 A CN 2011800288738A CN 201180028873 A CN201180028873 A CN 201180028873A CN 103181025 A CN103181025 A CN 103181025A
- Authority
- CN
- China
- Prior art keywords
- silk
- matrix
- electronic unit
- graphical
- meta
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000000034 method Methods 0.000 claims abstract description 106
- 239000000463 material Substances 0.000 claims description 270
- 239000011159 matrix material Substances 0.000 claims description 215
- 239000010408 film Substances 0.000 claims description 128
- 239000000758 substrate Substances 0.000 claims description 82
- 230000004044 response Effects 0.000 claims description 80
- 108010022355 Fibroins Proteins 0.000 claims description 73
- 238000004519 manufacturing process Methods 0.000 claims description 64
- 239000000243 solution Substances 0.000 claims description 53
- 108090000623 proteins and genes Proteins 0.000 claims description 41
- 102000004169 proteins and genes Human genes 0.000 claims description 37
- 239000002019 doping agent Substances 0.000 claims description 35
- 230000005670 electromagnetic radiation Effects 0.000 claims description 29
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 28
- 239000003292 glue Substances 0.000 claims description 26
- 238000005345 coagulation Methods 0.000 claims description 25
- 230000015271 coagulation Effects 0.000 claims description 25
- 239000010931 gold Substances 0.000 claims description 22
- 239000004411 aluminium Substances 0.000 claims description 18
- 229910052782 aluminium Inorganic materials 0.000 claims description 18
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 claims description 18
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 claims description 15
- 229910052737 gold Inorganic materials 0.000 claims description 15
- 230000010287 polarization Effects 0.000 claims description 14
- -1 fit Substances 0.000 claims description 13
- 102000004190 Enzymes Human genes 0.000 claims description 12
- 108090000790 Enzymes Proteins 0.000 claims description 12
- 239000003814 drug Substances 0.000 claims description 12
- 239000003102 growth factor Substances 0.000 claims description 11
- 108090000765 processed proteins & peptides Proteins 0.000 claims description 11
- 230000005855 radiation Effects 0.000 claims description 11
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 claims description 9
- 239000007864 aqueous solution Substances 0.000 claims description 9
- 229910052802 copper Inorganic materials 0.000 claims description 9
- 239000010949 copper Substances 0.000 claims description 9
- 230000003746 surface roughness Effects 0.000 claims description 9
- 238000001035 drying Methods 0.000 claims description 8
- 239000012634 fragment Substances 0.000 claims description 8
- KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 claims description 7
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 claims description 7
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 claims description 6
- PXHVJJICTQNCMI-UHFFFAOYSA-N Nickel Chemical compound [Ni] PXHVJJICTQNCMI-UHFFFAOYSA-N 0.000 claims description 6
- 150000001875 compounds Chemical class 0.000 claims description 6
- 238000001540 jet deposition Methods 0.000 claims description 6
- 239000000975 dye Substances 0.000 claims description 5
- 239000005556 hormone Substances 0.000 claims description 5
- 229940088597 hormone Drugs 0.000 claims description 5
- 239000000017 hydrogel Substances 0.000 claims description 5
- VYZAMTAEIAYCRO-UHFFFAOYSA-N Chromium Chemical compound [Cr] VYZAMTAEIAYCRO-UHFFFAOYSA-N 0.000 claims description 4
- 229910052804 chromium Inorganic materials 0.000 claims description 4
- 239000011651 chromium Substances 0.000 claims description 4
- 102000039446 nucleic acids Human genes 0.000 claims description 4
- 108020004707 nucleic acids Proteins 0.000 claims description 4
- 150000007523 nucleic acids Chemical class 0.000 claims description 4
- 238000000926 separation method Methods 0.000 claims description 4
- 229910052709 silver Inorganic materials 0.000 claims description 4
- 239000004332 silver Substances 0.000 claims description 4
- WFKWXMTUELFFGS-UHFFFAOYSA-N tungsten Chemical compound [W] WFKWXMTUELFFGS-UHFFFAOYSA-N 0.000 claims description 4
- 229910052721 tungsten Inorganic materials 0.000 claims description 4
- 239000010937 tungsten Substances 0.000 claims description 4
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 claims description 3
- ZOKXTWBITQBERF-UHFFFAOYSA-N Molybdenum Chemical compound [Mo] ZOKXTWBITQBERF-UHFFFAOYSA-N 0.000 claims description 3
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 claims description 3
- RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 claims description 3
- QCWXUUIWCKQGHC-UHFFFAOYSA-N Zirconium Chemical compound [Zr] QCWXUUIWCKQGHC-UHFFFAOYSA-N 0.000 claims description 3
- 230000002155 anti-virotic effect Effects 0.000 claims description 3
- 230000003115 biocidal effect Effects 0.000 claims description 3
- 229910017052 cobalt Inorganic materials 0.000 claims description 3
- 239000010941 cobalt Substances 0.000 claims description 3
- GUTLYIVDDKVIGB-UHFFFAOYSA-N cobalt atom Chemical compound [Co] GUTLYIVDDKVIGB-UHFFFAOYSA-N 0.000 claims description 3
- 239000004020 conductor Substances 0.000 claims description 3
- 239000006260 foam Substances 0.000 claims description 3
- 229910052741 iridium Inorganic materials 0.000 claims description 3
- GKOZUEZYRPOHIO-UHFFFAOYSA-N iridium atom Chemical compound [Ir] GKOZUEZYRPOHIO-UHFFFAOYSA-N 0.000 claims description 3
- 229910052742 iron Inorganic materials 0.000 claims description 3
- 239000011777 magnesium Substances 0.000 claims description 3
- 229910052749 magnesium Inorganic materials 0.000 claims description 3
- 239000004005 microsphere Substances 0.000 claims description 3
- 229910052750 molybdenum Inorganic materials 0.000 claims description 3
- 239000011733 molybdenum Substances 0.000 claims description 3
- 229910052759 nickel Inorganic materials 0.000 claims description 3
- 229910052763 palladium Inorganic materials 0.000 claims description 3
- 229910052697 platinum Inorganic materials 0.000 claims description 3
- 229910052703 rhodium Inorganic materials 0.000 claims description 3
- 239000010948 rhodium Substances 0.000 claims description 3
- MHOVAHRLVXNVSD-UHFFFAOYSA-N rhodium atom Chemical compound [Rh] MHOVAHRLVXNVSD-UHFFFAOYSA-N 0.000 claims description 3
- 229910052715 tantalum Inorganic materials 0.000 claims description 3
- GUVRBAGPIYLISA-UHFFFAOYSA-N tantalum atom Chemical compound [Ta] GUVRBAGPIYLISA-UHFFFAOYSA-N 0.000 claims description 3
- 229910052719 titanium Inorganic materials 0.000 claims description 3
- 239000010936 titanium Substances 0.000 claims description 3
- 231100000765 toxin Toxicity 0.000 claims description 3
- 229910052726 zirconium Inorganic materials 0.000 claims description 3
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims description 2
- 108091034117 Oligonucleotide Proteins 0.000 claims description 2
- 108091093037 Peptide nucleic acid Proteins 0.000 claims description 2
- 241000700605 Viruses Species 0.000 claims description 2
- JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 claims description 2
- 238000002512 chemotherapy Methods 0.000 claims description 2
- 230000018044 dehydration Effects 0.000 claims description 2
- 238000006297 dehydration reaction Methods 0.000 claims description 2
- 229910002804 graphite Inorganic materials 0.000 claims description 2
- 239000010439 graphite Substances 0.000 claims description 2
- 238000003306 harvesting Methods 0.000 claims description 2
- MRNHPUHPBOKKQT-UHFFFAOYSA-N indium;tin;hydrate Chemical compound O.[In].[Sn] MRNHPUHPBOKKQT-UHFFFAOYSA-N 0.000 claims description 2
- 150000002484 inorganic compounds Chemical class 0.000 claims description 2
- 229910010272 inorganic material Inorganic materials 0.000 claims description 2
- 239000002773 nucleotide Substances 0.000 claims description 2
- 125000003729 nucleotide group Chemical group 0.000 claims description 2
- 150000002894 organic compounds Chemical class 0.000 claims description 2
- 229910021420 polycrystalline silicon Inorganic materials 0.000 claims description 2
- 229920005591 polysilicon Polymers 0.000 claims description 2
- 239000000651 prodrug Substances 0.000 claims description 2
- 229940002612 prodrug Drugs 0.000 claims description 2
- 239000003053 toxin Substances 0.000 claims description 2
- 230000003444 anaesthetic effect Effects 0.000 claims 1
- 239000004599 antimicrobial Substances 0.000 claims 1
- 229910052735 hafnium Inorganic materials 0.000 claims 1
- VBJZVLUMGGDVMO-UHFFFAOYSA-N hafnium atom Chemical compound [Hf] VBJZVLUMGGDVMO-UHFFFAOYSA-N 0.000 claims 1
- 229930014550 juvenile hormone Natural products 0.000 claims 1
- 239000002949 juvenile hormone Substances 0.000 claims 1
- 150000003633 juvenile hormone derivatives Chemical class 0.000 claims 1
- 230000002186 photoactivation Effects 0.000 claims 1
- 229910052751 metal Inorganic materials 0.000 description 52
- 239000002184 metal Substances 0.000 description 52
- 238000012545 processing Methods 0.000 description 49
- 230000008569 process Effects 0.000 description 39
- 239000000523 sample Substances 0.000 description 39
- 230000008859 change Effects 0.000 description 36
- 235000018102 proteins Nutrition 0.000 description 36
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 33
- 229910052710 silicon Inorganic materials 0.000 description 33
- 239000010703 silicon Substances 0.000 description 33
- 238000005516 engineering process Methods 0.000 description 31
- 230000005540 biological transmission Effects 0.000 description 30
- 238000013461 design Methods 0.000 description 29
- 210000004027 cell Anatomy 0.000 description 26
- 239000012460 protein solution Substances 0.000 description 22
- 241000255789 Bombyx mori Species 0.000 description 20
- 239000003795 chemical substances by application Substances 0.000 description 20
- 230000003287 optical effect Effects 0.000 description 17
- 238000010023 transfer printing Methods 0.000 description 17
- 229920001222 biopolymer Polymers 0.000 description 16
- 238000000151 deposition Methods 0.000 description 16
- 230000008021 deposition Effects 0.000 description 16
- 230000006870 function Effects 0.000 description 16
- 239000000499 gel Substances 0.000 description 16
- 238000001259 photo etching Methods 0.000 description 16
- 241000239290 Araneae Species 0.000 description 15
- AMXOYNBUYSYVKV-UHFFFAOYSA-M lithium bromide Chemical compound [Li+].[Br-] AMXOYNBUYSYVKV-UHFFFAOYSA-M 0.000 description 14
- 238000001228 spectrum Methods 0.000 description 14
- 238000011282 treatment Methods 0.000 description 14
- 150000001413 amino acids Chemical class 0.000 description 12
- 230000015572 biosynthetic process Effects 0.000 description 12
- 238000005530 etching Methods 0.000 description 12
- 238000002347 injection Methods 0.000 description 12
- 239000007924 injection Substances 0.000 description 12
- 239000010409 thin film Substances 0.000 description 12
- 230000003213 activating effect Effects 0.000 description 11
- 238000006243 chemical reaction Methods 0.000 description 11
- 230000000694 effects Effects 0.000 description 11
- 229940088598 enzyme Drugs 0.000 description 11
- 238000002474 experimental method Methods 0.000 description 10
- 239000000835 fiber Substances 0.000 description 10
- 238000005259 measurement Methods 0.000 description 10
- 229920000642 polymer Polymers 0.000 description 10
- 238000001878 scanning electron micrograph Methods 0.000 description 10
- 239000000126 substance Substances 0.000 description 10
- 230000008093 supporting effect Effects 0.000 description 10
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 9
- 238000011161 development Methods 0.000 description 9
- 230000018109 developmental process Effects 0.000 description 9
- 229910052760 oxygen Inorganic materials 0.000 description 9
- 239000001301 oxygen Substances 0.000 description 9
- 229920002120 photoresistant polymer Polymers 0.000 description 9
- 239000002390 adhesive tape Substances 0.000 description 8
- 230000007613 environmental effect Effects 0.000 description 8
- 238000001704 evaporation Methods 0.000 description 8
- 230000008020 evaporation Effects 0.000 description 8
- 238000002360 preparation method Methods 0.000 description 8
- 125000006850 spacer group Chemical group 0.000 description 8
- 230000010148 water-pollination Effects 0.000 description 8
- 238000001039 wet etching Methods 0.000 description 8
- 235000001014 amino acid Nutrition 0.000 description 7
- 229940024606 amino acid Drugs 0.000 description 7
- 238000005266 casting Methods 0.000 description 7
- 239000003153 chemical reaction reagent Substances 0.000 description 7
- 230000000875 corresponding effect Effects 0.000 description 7
- 239000012071 phase Substances 0.000 description 7
- 230000000886 photobiology Effects 0.000 description 7
- 238000010521 absorption reaction Methods 0.000 description 6
- 238000003491 array Methods 0.000 description 6
- 239000012620 biological material Substances 0.000 description 6
- 238000000502 dialysis Methods 0.000 description 6
- 230000005684 electric field Effects 0.000 description 6
- 230000002209 hydrophobic effect Effects 0.000 description 6
- 230000003993 interaction Effects 0.000 description 6
- CEQFOVLGLXCDCX-WUKNDPDISA-N methyl red Chemical compound C1=CC(N(C)C)=CC=C1\N=N\C1=CC=CC=C1C(O)=O CEQFOVLGLXCDCX-WUKNDPDISA-N 0.000 description 6
- 239000000203 mixture Substances 0.000 description 6
- 239000000853 adhesive Substances 0.000 description 5
- 230000001070 adhesive effect Effects 0.000 description 5
- 239000011248 coating agent Substances 0.000 description 5
- 238000000576 coating method Methods 0.000 description 5
- 239000013078 crystal Substances 0.000 description 5
- 238000007639 printing Methods 0.000 description 5
- 238000011160 research Methods 0.000 description 5
- 239000002904 solvent Substances 0.000 description 5
- 241000894007 species Species 0.000 description 5
- 229960000575 trastuzumab Drugs 0.000 description 5
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 4
- 240000000249 Morus alba Species 0.000 description 4
- 235000008708 Morus alba Nutrition 0.000 description 4
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 4
- 229920001872 Spider silk Polymers 0.000 description 4
- 239000008280 blood Substances 0.000 description 4
- 210000004369 blood Anatomy 0.000 description 4
- 210000004556 brain Anatomy 0.000 description 4
- 230000001276 controlling effect Effects 0.000 description 4
- 238000001514 detection method Methods 0.000 description 4
- 229940079593 drug Drugs 0.000 description 4
- 230000005611 electricity Effects 0.000 description 4
- 235000013305 food Nutrition 0.000 description 4
- 239000007789 gas Substances 0.000 description 4
- 210000004907 gland Anatomy 0.000 description 4
- 238000009434 installation Methods 0.000 description 4
- 229940059936 lithium bromide Drugs 0.000 description 4
- 238000012544 monitoring process Methods 0.000 description 4
- 238000001020 plasma etching Methods 0.000 description 4
- 239000013558 reference substance Substances 0.000 description 4
- 238000001338 self-assembly Methods 0.000 description 4
- 239000004065 semiconductor Substances 0.000 description 4
- 210000003491 skin Anatomy 0.000 description 4
- 239000007787 solid Substances 0.000 description 4
- SFZCNBIFKDRMGX-UHFFFAOYSA-N sulfur hexafluoride Chemical compound FS(F)(F)(F)(F)F SFZCNBIFKDRMGX-UHFFFAOYSA-N 0.000 description 4
- 229960000909 sulfur hexafluoride Drugs 0.000 description 4
- 238000010408 sweeping Methods 0.000 description 4
- 238000012360 testing method Methods 0.000 description 4
- 238000000411 transmission spectrum Methods 0.000 description 4
- 229910052720 vanadium Inorganic materials 0.000 description 4
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
- 241000894006 Bacteria Species 0.000 description 3
- 241000196324 Embryophyta Species 0.000 description 3
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 3
- 108090000288 Glycoproteins Proteins 0.000 description 3
- 102000003886 Glycoproteins Human genes 0.000 description 3
- 241000238631 Hexapoda Species 0.000 description 3
- LEVWYRKDKASIDU-IMJSIDKUSA-N L-cystine Chemical compound [O-]C(=O)[C@@H]([NH3+])CSSC[C@H]([NH3+])C([O-])=O LEVWYRKDKASIDU-IMJSIDKUSA-N 0.000 description 3
- 241000833020 Padilla Species 0.000 description 3
- 239000004098 Tetracycline Substances 0.000 description 3
- 210000001015 abdomen Anatomy 0.000 description 3
- 230000002411 adverse Effects 0.000 description 3
- 239000012491 analyte Substances 0.000 description 3
- 238000004458 analytical method Methods 0.000 description 3
- 230000006399 behavior Effects 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- 230000008827 biological function Effects 0.000 description 3
- 239000003990 capacitor Substances 0.000 description 3
- 238000002425 crystallisation Methods 0.000 description 3
- 230000008025 crystallization Effects 0.000 description 3
- 125000004122 cyclic group Chemical group 0.000 description 3
- 229960003067 cystine Drugs 0.000 description 3
- 238000001312 dry etching Methods 0.000 description 3
- 230000005672 electromagnetic field Effects 0.000 description 3
- 238000005566 electron beam evaporation Methods 0.000 description 3
- 239000002657 fibrous material Substances 0.000 description 3
- 239000008103 glucose Substances 0.000 description 3
- 229910052740 iodine Inorganic materials 0.000 description 3
- 150000002500 ions Chemical class 0.000 description 3
- 238000002955 isolation Methods 0.000 description 3
- 229920002521 macromolecule Polymers 0.000 description 3
- 238000012986 modification Methods 0.000 description 3
- 230000004048 modification Effects 0.000 description 3
- 238000000465 moulding Methods 0.000 description 3
- 229910052755 nonmetal Inorganic materials 0.000 description 3
- 210000000056 organ Anatomy 0.000 description 3
- 229920001184 polypeptide Polymers 0.000 description 3
- 150000008442 polyphenolic compounds Polymers 0.000 description 3
- 235000013824 polyphenols Nutrition 0.000 description 3
- 102000004196 processed proteins & peptides Human genes 0.000 description 3
- 238000007348 radical reaction Methods 0.000 description 3
- 230000003595 spectral effect Effects 0.000 description 3
- 239000007921 spray Substances 0.000 description 3
- 238000009718 spray deposition Methods 0.000 description 3
- 229910052717 sulfur Inorganic materials 0.000 description 3
- 229960002180 tetracycline Drugs 0.000 description 3
- 229930101283 tetracycline Natural products 0.000 description 3
- 235000019364 tetracycline Nutrition 0.000 description 3
- 150000003522 tetracyclines Chemical class 0.000 description 3
- 210000001519 tissue Anatomy 0.000 description 3
- 229910052727 yttrium Inorganic materials 0.000 description 3
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 2
- 229920000856 Amylose Polymers 0.000 description 2
- 108010035532 Collagen Proteins 0.000 description 2
- 102000008186 Collagen Human genes 0.000 description 2
- 244000247747 Coptis groenlandica Species 0.000 description 2
- 235000002991 Coptis groenlandica Nutrition 0.000 description 2
- ULGZDMOVFRHVEP-RWJQBGPGSA-N Erythromycin Chemical compound O([C@@H]1[C@@H](C)C(=O)O[C@@H]([C@@]([C@H](O)[C@@H](C)C(=O)[C@H](C)C[C@@](C)(O)[C@H](O[C@H]2[C@@H]([C@H](C[C@@H](C)O2)N(C)C)O)[C@H]1C)(C)O)CC)[C@H]1C[C@@](C)(OC)[C@@H](O)[C@H](C)O1 ULGZDMOVFRHVEP-RWJQBGPGSA-N 0.000 description 2
- 238000005033 Fourier transform infrared spectroscopy Methods 0.000 description 2
- 241000255896 Galleria mellonella Species 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- 239000004471 Glycine Substances 0.000 description 2
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 2
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- 101710172711 Structural protein Proteins 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 235000004279 alanine Nutrition 0.000 description 2
- 239000000730 antalgic agent Substances 0.000 description 2
- 239000011324 bead Substances 0.000 description 2
- 238000005452 bending Methods 0.000 description 2
- 230000000975 bioactive effect Effects 0.000 description 2
- 238000006065 biodegradation reaction Methods 0.000 description 2
- 210000000988 bone and bone Anatomy 0.000 description 2
- 238000004364 calculation method Methods 0.000 description 2
- 239000002775 capsule Substances 0.000 description 2
- 230000015556 catabolic process Effects 0.000 description 2
- AFZFFLVORLEPPO-UVYJNCLZSA-N cefditoren pivoxil Chemical compound S([C@@H]1[C@@H](C(N1C=1C(=O)OCOC(=O)C(C)(C)C)=O)NC(=O)\C(=N/OC)C=2N=C(N)SC=2)CC=1\C=C/C=1SC=NC=1C AFZFFLVORLEPPO-UVYJNCLZSA-N 0.000 description 2
- 229920002678 cellulose Polymers 0.000 description 2
- 239000001913 cellulose Substances 0.000 description 2
- 239000005482 chemotactic factor Substances 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N chloroform Substances ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- MYSWGUAQZAJSOK-UHFFFAOYSA-N ciprofloxacin Chemical compound C12=CC(N3CCNCC3)=C(F)C=C2C(=O)C(C(=O)O)=CN1C1CC1 MYSWGUAQZAJSOK-UHFFFAOYSA-N 0.000 description 2
- 229920001436 collagen Polymers 0.000 description 2
- 239000000084 colloidal system Substances 0.000 description 2
- 238000005094 computer simulation Methods 0.000 description 2
- 238000010276 construction Methods 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 238000005336 cracking Methods 0.000 description 2
- 238000005520 cutting process Methods 0.000 description 2
- 238000006731 degradation reaction Methods 0.000 description 2
- 239000008367 deionised water Substances 0.000 description 2
- 229910021641 deionized water Inorganic materials 0.000 description 2
- 238000010586 diagram Methods 0.000 description 2
- 238000009826 distribution Methods 0.000 description 2
- 238000005868 electrolysis reaction Methods 0.000 description 2
- 238000010894 electron beam technology Methods 0.000 description 2
- AEUTYOVWOVBAKS-UWVGGRQHSA-N ethambutol Chemical compound CC[C@@H](CO)NCCN[C@@H](CC)CO AEUTYOVWOVBAKS-UWVGGRQHSA-N 0.000 description 2
- 239000000284 extract Substances 0.000 description 2
- 239000007888 film coating Substances 0.000 description 2
- 238000009501 film coating Methods 0.000 description 2
- 229940063190 flagyl Drugs 0.000 description 2
- 239000012530 fluid Substances 0.000 description 2
- 239000011521 glass Substances 0.000 description 2
- 230000012010 growth Effects 0.000 description 2
- 239000001307 helium Substances 0.000 description 2
- 229910052734 helium Inorganic materials 0.000 description 2
- SWQJXJOGLNCZEY-UHFFFAOYSA-N helium atom Chemical compound [He] SWQJXJOGLNCZEY-UHFFFAOYSA-N 0.000 description 2
- 229910052739 hydrogen Inorganic materials 0.000 description 2
- 239000001257 hydrogen Substances 0.000 description 2
- 150000002466 imines Chemical class 0.000 description 2
- 238000001727 in vivo Methods 0.000 description 2
- 238000007641 inkjet printing Methods 0.000 description 2
- 150000002605 large molecules Chemical class 0.000 description 2
- 230000000670 limiting effect Effects 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 239000004973 liquid crystal related substance Substances 0.000 description 2
- 210000005229 liver cell Anatomy 0.000 description 2
- 230000007246 mechanism Effects 0.000 description 2
- 239000002609 medium Substances 0.000 description 2
- 239000012528 membrane Substances 0.000 description 2
- 238000009992 mercerising Methods 0.000 description 2
- VNWKTOKETHGBQD-UHFFFAOYSA-N methane Chemical compound C VNWKTOKETHGBQD-UHFFFAOYSA-N 0.000 description 2
- FPTPAIQTXYFGJC-UHFFFAOYSA-N metronidazole hydrochloride Chemical group Cl.CC1=NC=C([N+]([O-])=O)N1CCO FPTPAIQTXYFGJC-UHFFFAOYSA-N 0.000 description 2
- 230000036961 partial effect Effects 0.000 description 2
- 239000002245 particle Substances 0.000 description 2
- 230000035699 permeability Effects 0.000 description 2
- 235000020030 perry Nutrition 0.000 description 2
- 238000000206 photolithography Methods 0.000 description 2
- 239000006187 pill Substances 0.000 description 2
- 229920003229 poly(methyl methacrylate) Polymers 0.000 description 2
- 229920001610 polycaprolactone Polymers 0.000 description 2
- 239000004632 polycaprolactone Substances 0.000 description 2
- 229920001223 polyethylene glycol Polymers 0.000 description 2
- 239000004926 polymethyl methacrylate Substances 0.000 description 2
- 239000002243 precursor Substances 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 238000002310 reflectometry Methods 0.000 description 2
- 230000003252 repetitive effect Effects 0.000 description 2
- 238000012827 research and development Methods 0.000 description 2
- 230000000630 rising effect Effects 0.000 description 2
- 238000010008 shearing Methods 0.000 description 2
- 229910000029 sodium carbonate Inorganic materials 0.000 description 2
- 210000004872 soft tissue Anatomy 0.000 description 2
- 238000009987 spinning Methods 0.000 description 2
- 230000003068 static effect Effects 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- 229940124597 therapeutic agent Drugs 0.000 description 2
- 238000002207 thermal evaporation Methods 0.000 description 2
- OTVAEFIXJLOWRX-NXEZZACHSA-N thiamphenicol Chemical compound CS(=O)(=O)C1=CC=C([C@@H](O)[C@@H](CO)NC(=O)C(Cl)Cl)C=C1 OTVAEFIXJLOWRX-NXEZZACHSA-N 0.000 description 2
- 229960003053 thiamphenicol Drugs 0.000 description 2
- 210000001685 thyroid gland Anatomy 0.000 description 2
- 238000012876 topography Methods 0.000 description 2
- 230000009261 transgenic effect Effects 0.000 description 2
- 238000001947 vapour-phase growth Methods 0.000 description 2
- 238000001429 visible spectrum Methods 0.000 description 2
- 230000000007 visual effect Effects 0.000 description 2
- 238000009941 weaving Methods 0.000 description 2
- 239000002023 wood Substances 0.000 description 2
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 1
- DQJCDTNMLBYVAY-ZXXIYAEKSA-N (2S,5R,10R,13R)-16-{[(2R,3S,4R,5R)-3-{[(2S,3R,4R,5S,6R)-3-acetamido-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-5-(ethylamino)-6-hydroxy-2-(hydroxymethyl)oxan-4-yl]oxy}-5-(4-aminobutyl)-10-carbamoyl-2,13-dimethyl-4,7,12,15-tetraoxo-3,6,11,14-tetraazaheptadecan-1-oic acid Chemical compound NCCCC[C@H](C(=O)N[C@@H](C)C(O)=O)NC(=O)CC[C@H](C(N)=O)NC(=O)[C@@H](C)NC(=O)C(C)O[C@@H]1[C@@H](NCC)C(O)O[C@H](CO)[C@H]1O[C@H]1[C@H](NC(C)=O)[C@@H](O)[C@H](O)[C@@H](CO)O1 DQJCDTNMLBYVAY-ZXXIYAEKSA-N 0.000 description 1
- JCZPMGDSEAFWDY-SQOUGZDYSA-N (2r,3s,4r,5r)-2,3,4,5,6-pentahydroxyhexanamide Chemical compound NC(=O)[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO JCZPMGDSEAFWDY-SQOUGZDYSA-N 0.000 description 1
- FFTVPQUHLQBXQZ-KVUCHLLUSA-N (4s,4as,5ar,12ar)-4,7-bis(dimethylamino)-1,10,11,12a-tetrahydroxy-3,12-dioxo-4a,5,5a,6-tetrahydro-4h-tetracene-2-carboxamide Chemical compound C1C2=C(N(C)C)C=CC(O)=C2C(O)=C2[C@@H]1C[C@H]1[C@H](N(C)C)C(=O)C(C(N)=O)=C(O)[C@@]1(O)C2=O FFTVPQUHLQBXQZ-KVUCHLLUSA-N 0.000 description 1
- MINDHVHHQZYEEK-UHFFFAOYSA-N (E)-(2S,3R,4R,5S)-5-[(2S,3S,4S,5S)-2,3-epoxy-5-hydroxy-4-methylhexyl]tetrahydro-3,4-dihydroxy-(beta)-methyl-2H-pyran-2-crotonic acid ester with 9-hydroxynonanoic acid Natural products CC(O)C(C)C1OC1CC1C(O)C(O)C(CC(C)=CC(=O)OCCCCCCCCC(O)=O)OC1 MINDHVHHQZYEEK-UHFFFAOYSA-N 0.000 description 1
- XUBOMFCQGDBHNK-JTQLQIEISA-N (S)-gatifloxacin Chemical compound FC1=CC(C(C(C(O)=O)=CN2C3CC3)=O)=C2C(OC)=C1N1CCN[C@@H](C)C1 XUBOMFCQGDBHNK-JTQLQIEISA-N 0.000 description 1
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 1
- RTQWWZBSTRGEAV-PKHIMPSTSA-N 2-[[(2s)-2-[bis(carboxymethyl)amino]-3-[4-(methylcarbamoylamino)phenyl]propyl]-[2-[bis(carboxymethyl)amino]propyl]amino]acetic acid Chemical compound CNC(=O)NC1=CC=C(C[C@@H](CN(CC(C)N(CC(O)=O)CC(O)=O)CC(O)=O)N(CC(O)=O)CC(O)=O)C=C1 RTQWWZBSTRGEAV-PKHIMPSTSA-N 0.000 description 1
- WZRJTRPJURQBRM-UHFFFAOYSA-N 4-amino-n-(5-methyl-1,2-oxazol-3-yl)benzenesulfonamide;5-[(3,4,5-trimethoxyphenyl)methyl]pyrimidine-2,4-diamine Chemical compound O1C(C)=CC(NS(=O)(=O)C=2C=CC(N)=CC=2)=N1.COC1=C(OC)C(OC)=CC(CC=2C(=NC(N)=NC=2)N)=C1 WZRJTRPJURQBRM-UHFFFAOYSA-N 0.000 description 1
- UQVADGKRJSPTBY-UHFFFAOYSA-N 4-benzyl-5-methoxypyrimidin-2-amine Chemical compound O(C)C=1C(=NC(=NC1)N)CC1=CC=CC=C1 UQVADGKRJSPTBY-UHFFFAOYSA-N 0.000 description 1
- GSDSWSVVBLHKDQ-UHFFFAOYSA-N 9-fluoro-3-methyl-10-(4-methylpiperazin-1-yl)-7-oxo-2,3-dihydro-7H-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylic acid Chemical compound FC1=CC(C(C(C(O)=O)=C2)=O)=C3N2C(C)COC3=C1N1CCN(C)CC1 GSDSWSVVBLHKDQ-UHFFFAOYSA-N 0.000 description 1
- 108010013043 Acetylesterase Proteins 0.000 description 1
- 229920000936 Agarose Polymers 0.000 description 1
- 239000004382 Amylase Substances 0.000 description 1
- 102000013142 Amylases Human genes 0.000 description 1
- 108010065511 Amylases Proteins 0.000 description 1
- 241000256844 Apis mellifera Species 0.000 description 1
- 108091023037 Aptamer Proteins 0.000 description 1
- 241000239223 Arachnida Species 0.000 description 1
- 241001598873 Argiope amoena Species 0.000 description 1
- 241000238421 Arthropoda Species 0.000 description 1
- 241001232245 Asida lepidoptera Species 0.000 description 1
- 241000193830 Bacillus <bacterium> Species 0.000 description 1
- 108010001478 Bacitracin Proteins 0.000 description 1
- 108010082845 Bacteriorhodopsins Proteins 0.000 description 1
- 241000093720 Berzelia arachnoidea Species 0.000 description 1
- 241000255791 Bombyx Species 0.000 description 1
- 241000255794 Bombyx mandarina Species 0.000 description 1
- 101001052041 Bombyx mori Fibroin heavy chain Proteins 0.000 description 1
- 241000167854 Bourreria succulenta Species 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 1
- 229930186147 Cephalosporin Natural products 0.000 description 1
- 229920002101 Chitin Polymers 0.000 description 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 1
- 108020004414 DNA Proteins 0.000 description 1
- 102000016928 DNA-directed DNA polymerase Human genes 0.000 description 1
- 108010014303 DNA-directed DNA polymerase Proteins 0.000 description 1
- MQJKPEGWNLWLTK-UHFFFAOYSA-N Dapsone Chemical compound C1=CC(N)=CC=C1S(=O)(=O)C1=CC=C(N)C=C1 MQJKPEGWNLWLTK-UHFFFAOYSA-N 0.000 description 1
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 description 1
- 102400001047 Endostatin Human genes 0.000 description 1
- 108010079505 Endostatins Proteins 0.000 description 1
- 102000009024 Epidermal Growth Factor Human genes 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- VGGSQFUCUMXWEO-UHFFFAOYSA-N Ethene Chemical compound C=C VGGSQFUCUMXWEO-UHFFFAOYSA-N 0.000 description 1
- 102000018233 Fibroblast Growth Factor Human genes 0.000 description 1
- 108050007372 Fibroblast Growth Factor Proteins 0.000 description 1
- 102000016359 Fibronectins Human genes 0.000 description 1
- 108010067306 Fibronectins Proteins 0.000 description 1
- UIOFUWFRIANQPC-JKIFEVAISA-N Floxacillin Chemical compound N([C@@H]1C(N2[C@H](C(C)(C)S[C@@H]21)C(O)=O)=O)C(=O)C1=C(C)ON=C1C1=C(F)C=CC=C1Cl UIOFUWFRIANQPC-JKIFEVAISA-N 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- 239000004366 Glucose oxidase Substances 0.000 description 1
- 108010015776 Glucose oxidase Proteins 0.000 description 1
- 108010015899 Glycopeptides Proteins 0.000 description 1
- 102000002068 Glycopeptides Human genes 0.000 description 1
- YZCKVEUIGOORGS-UHFFFAOYSA-N Hydrogen atom Chemical compound [H] YZCKVEUIGOORGS-UHFFFAOYSA-N 0.000 description 1
- 241000257303 Hymenoptera Species 0.000 description 1
- 108090000723 Insulin-Like Growth Factor I Proteins 0.000 description 1
- 108010076876 Keratins Proteins 0.000 description 1
- 102000011782 Keratins Human genes 0.000 description 1
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 1
- 108010029541 Laccase Proteins 0.000 description 1
- 241000238866 Latrodectus mactans Species 0.000 description 1
- 102000003960 Ligases Human genes 0.000 description 1
- 108090000364 Ligases Proteins 0.000 description 1
- 108090001060 Lipase Proteins 0.000 description 1
- 102000004882 Lipase Human genes 0.000 description 1
- 239000004367 Lipase Substances 0.000 description 1
- 108090001030 Lipoproteins Proteins 0.000 description 1
- 102000004895 Lipoproteins Human genes 0.000 description 1
- 241000186781 Listeria Species 0.000 description 1
- LSDPWZHWYPCBBB-UHFFFAOYSA-N Methanethiol Chemical compound SC LSDPWZHWYPCBBB-UHFFFAOYSA-N 0.000 description 1
- 239000012901 Milli-Q water Substances 0.000 description 1
- 241000918728 Monotes Species 0.000 description 1
- BLXXJMDCKKHMKV-UHFFFAOYSA-N Nabumetone Chemical compound C1=C(CCC(C)=O)C=CC2=CC(OC)=CC=C21 BLXXJMDCKKHMKV-UHFFFAOYSA-N 0.000 description 1
- 229930193140 Neomycin Natural products 0.000 description 1
- 241000238903 Nephila Species 0.000 description 1
- 108010025020 Nerve Growth Factor Proteins 0.000 description 1
- 102000015336 Nerve Growth Factor Human genes 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- 229930182555 Penicillin Natural products 0.000 description 1
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 1
- 102000003992 Peroxidases Human genes 0.000 description 1
- 241000332308 Pisauridae Species 0.000 description 1
- 108010038512 Platelet-Derived Growth Factor Proteins 0.000 description 1
- 102000010780 Platelet-Derived Growth Factor Human genes 0.000 description 1
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 229920000954 Polyglycolide Polymers 0.000 description 1
- 108010039918 Polylysine Proteins 0.000 description 1
- 239000004793 Polystyrene Substances 0.000 description 1
- 101710098940 Pro-epidermal growth factor Proteins 0.000 description 1
- 102000004330 Rhodopsin Human genes 0.000 description 1
- 108090000820 Rhodopsin Proteins 0.000 description 1
- 241001620634 Roger Species 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- 241000607142 Salmonella Species 0.000 description 1
- 108020004459 Small interfering RNA Proteins 0.000 description 1
- 229920002125 Sokalan® Polymers 0.000 description 1
- 102000013275 Somatomedins Human genes 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 229920001963 Synthetic biodegradable polymer Polymers 0.000 description 1
- 102000009618 Transforming Growth Factors Human genes 0.000 description 1
- 108010009583 Transforming Growth Factors Proteins 0.000 description 1
- 108010059993 Vancomycin Proteins 0.000 description 1
- 108010019530 Vascular Endothelial Growth Factors Proteins 0.000 description 1
- 102000005789 Vascular Endothelial Growth Factors Human genes 0.000 description 1
- 235000009754 Vitis X bourquina Nutrition 0.000 description 1
- 235000012333 Vitis X labruscana Nutrition 0.000 description 1
- 240000006365 Vitis vinifera Species 0.000 description 1
- 235000014787 Vitis vinifera Nutrition 0.000 description 1
- 244000126002 Ziziphus vulgaris Species 0.000 description 1
- XYVNHPYNSPGYLI-UUOKFMHZSA-N [(2r,3s,4r,5r)-5-(2-amino-6-oxo-3h-purin-9-yl)-4-hydroxy-2-(phosphonooxymethyl)oxolan-3-yl] dihydrogen phosphate Chemical compound C1=2NC(N)=NC(=O)C=2N=CN1[C@@H]1O[C@H](COP(O)(O)=O)[C@@H](OP(O)(O)=O)[C@H]1O XYVNHPYNSPGYLI-UUOKFMHZSA-N 0.000 description 1
- 229960000446 abciximab Drugs 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 239000006096 absorbing agent Substances 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 229960002964 adalimumab Drugs 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 210000001789 adipocyte Anatomy 0.000 description 1
- 230000001919 adrenal effect Effects 0.000 description 1
- 238000007605 air drying Methods 0.000 description 1
- 229920000615 alginic acid Polymers 0.000 description 1
- 235000010443 alginic acid Nutrition 0.000 description 1
- 229950009106 altumomab Drugs 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- 229940126575 aminoglycoside Drugs 0.000 description 1
- 229960003022 amoxicillin Drugs 0.000 description 1
- LSQZJLSUYDQPKJ-NJBDSQKTSA-N amoxicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=C(O)C=C1 LSQZJLSUYDQPKJ-NJBDSQKTSA-N 0.000 description 1
- AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 description 1
- 229960000723 ampicillin Drugs 0.000 description 1
- 235000019418 amylase Nutrition 0.000 description 1
- 230000001772 anti-angiogenic effect Effects 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 230000002924 anti-infective effect Effects 0.000 description 1
- 229940121363 anti-inflammatory agent Drugs 0.000 description 1
- 239000002260 anti-inflammatory agent Substances 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 239000003429 antifungal agent Substances 0.000 description 1
- 229940121375 antifungal agent Drugs 0.000 description 1
- 239000000427 antigen Substances 0.000 description 1
- 108091007433 antigens Proteins 0.000 description 1
- 102000036639 antigens Human genes 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 229920006231 aramid fiber Polymers 0.000 description 1
- 229950005725 arcitumomab Drugs 0.000 description 1
- 230000000712 assembly Effects 0.000 description 1
- 238000000429 assembly Methods 0.000 description 1
- KCGDLDVOVMXYDQ-UHFFFAOYSA-N azane;1,2,3,4-tetramethyl-5-phenylbenzene Chemical compound N.CC1=C(C)C(C)=CC(C=2C=CC=CC=2)=C1C KCGDLDVOVMXYDQ-UHFFFAOYSA-N 0.000 description 1
- 229960004099 azithromycin Drugs 0.000 description 1
- MQTOSJVFKKJCRP-BICOPXKESA-N azithromycin Chemical compound O([C@@H]1[C@@H](C)C(=O)O[C@@H]([C@@]([C@H](O)[C@@H](C)N(C)C[C@H](C)C[C@@](C)(O)[C@H](O[C@H]2[C@@H]([C@H](C[C@@H](C)O2)N(C)C)O)[C@H]1C)(C)O)CC)[C@H]1C[C@@](C)(OC)[C@@H](O)[C@H](C)O1 MQTOSJVFKKJCRP-BICOPXKESA-N 0.000 description 1
- 239000000987 azo dye Substances 0.000 description 1
- 150000003851 azoles Chemical class 0.000 description 1
- WZPBZJONDBGPKJ-VEHQQRBSSA-N aztreonam Chemical compound O=C1N(S([O-])(=O)=O)[C@@H](C)[C@@H]1NC(=O)C(=N/OC(C)(C)C(O)=O)\C1=CSC([NH3+])=N1 WZPBZJONDBGPKJ-VEHQQRBSSA-N 0.000 description 1
- 229960003644 aztreonam Drugs 0.000 description 1
- 229960003071 bacitracin Drugs 0.000 description 1
- 229930184125 bacitracin Natural products 0.000 description 1
- CLKOFPXJLQSYAH-ABRJDSQDSA-N bacitracin A Chemical compound C1SC([C@@H](N)[C@@H](C)CC)=N[C@@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]1C(=O)N[C@H](CCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@H](CC=2C=CC=CC=2)C(=O)N[C@@H](CC=2N=CNC=2)C(=O)N[C@H](CC(O)=O)C(=O)N[C@@H](CC(N)=O)C(=O)NCCCC1 CLKOFPXJLQSYAH-ABRJDSQDSA-N 0.000 description 1
- 238000003705 background correction Methods 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 229960004669 basiliximab Drugs 0.000 description 1
- 229950003269 bectumomab Drugs 0.000 description 1
- 229960000397 bevacizumab Drugs 0.000 description 1
- 229950001303 biciromab Drugs 0.000 description 1
- 210000000013 bile duct Anatomy 0.000 description 1
- 229960002685 biotin Drugs 0.000 description 1
- 235000020958 biotin Nutrition 0.000 description 1
- 239000011616 biotin Substances 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 229940034605 capromab pendetide Drugs 0.000 description 1
- 150000001718 carbodiimides Chemical class 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 210000004413 cardiac myocyte Anatomy 0.000 description 1
- 210000003321 cartilage cell Anatomy 0.000 description 1
- QYIYFLOTGYLRGG-GPCCPHFNSA-N cefaclor Chemical compound C1([C@H](C(=O)N[C@@H]2C(N3C(=C(Cl)CS[C@@H]32)C(O)=O)=O)N)=CC=CC=C1 QYIYFLOTGYLRGG-GPCCPHFNSA-N 0.000 description 1
- 229960005361 cefaclor Drugs 0.000 description 1
- 229960001139 cefazolin Drugs 0.000 description 1
- MLYYVTUWGNIJIB-BXKDBHETSA-N cefazolin Chemical compound S1C(C)=NN=C1SCC1=C(C(O)=O)N2C(=O)[C@@H](NC(=O)CN3N=NN=C3)[C@H]2SC1 MLYYVTUWGNIJIB-BXKDBHETSA-N 0.000 description 1
- VOAZJEPQLGBXGO-SDAWRPRTSA-N ceftobiprole Chemical compound S1C(N)=NC(C(=N\O)\C(=O)N[C@@H]2C(N3C(=C(\C=C/4C(N([C@H]5CNCC5)CC\4)=O)CS[C@@H]32)C(O)=O)=O)=N1 VOAZJEPQLGBXGO-SDAWRPRTSA-N 0.000 description 1
- 229950004259 ceftobiprole Drugs 0.000 description 1
- 238000004113 cell culture Methods 0.000 description 1
- 230000010261 cell growth Effects 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 229940124587 cephalosporin Drugs 0.000 description 1
- 150000001780 cephalosporins Chemical class 0.000 description 1
- 229960005395 cetuximab Drugs 0.000 description 1
- 230000003196 chaotropic effect Effects 0.000 description 1
- 238000012512 characterization method Methods 0.000 description 1
- JQXXHWHPUNPDRT-BQVAUQFYSA-N chembl1523493 Chemical compound O([C@](C1=O)(C)O\C=C/[C@@H]([C@H]([C@@H](OC(C)=O)[C@H](C)[C@H](O)[C@H](C)[C@@H](O)[C@@H](C)/C=C\C=C(C)/C(=O)NC=2C(O)=C3C(O)=C4C)C)OC)C4=C1C3=C(O)C=2C=NN1CCN(C)CC1 JQXXHWHPUNPDRT-BQVAUQFYSA-N 0.000 description 1
- 238000000701 chemical imaging Methods 0.000 description 1
- 231100000481 chemical toxicant Toxicity 0.000 description 1
- 235000019693 cherries Nutrition 0.000 description 1
- 229960005091 chloramphenicol Drugs 0.000 description 1
- WIIZWVCIJKGZOK-RKDXNWHRSA-N chloramphenicol Chemical compound ClC(Cl)C(=O)N[C@H](CO)[C@H](O)C1=CC=C([N+]([O-])=O)C=C1 WIIZWVCIJKGZOK-RKDXNWHRSA-N 0.000 description 1
- 239000000460 chlorine Substances 0.000 description 1
- 229910052801 chlorine Inorganic materials 0.000 description 1
- 229940060038 chlorine Drugs 0.000 description 1
- 229930002875 chlorophyll Natural products 0.000 description 1
- 235000019804 chlorophyll Nutrition 0.000 description 1
- ATNHDLDRLWWWCB-AENOIHSZSA-M chlorophyll a Chemical compound C1([C@@H](C(=O)OC)C(=O)C2=C3C)=C2N2C3=CC(C(CC)=C3C)=[N+]4C3=CC3=C(C=C)C(C)=C5N3[Mg-2]42[N+]2=C1[C@@H](CCC(=O)OC\C=C(/C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)[C@H](C)C2=C5 ATNHDLDRLWWWCB-AENOIHSZSA-M 0.000 description 1
- 210000001612 chondrocyte Anatomy 0.000 description 1
- 229960003405 ciprofloxacin Drugs 0.000 description 1
- 229960002227 clindamycin Drugs 0.000 description 1
- KDLRVYVGXIQJDK-AWPVFWJPSA-N clindamycin Chemical compound CN1C[C@H](CCC)C[C@H]1C(=O)N[C@H]([C@H](C)Cl)[C@@H]1[C@H](O)[C@H](O)[C@@H](O)[C@@H](SC)O1 KDLRVYVGXIQJDK-AWPVFWJPSA-N 0.000 description 1
- 229960004287 clofazimine Drugs 0.000 description 1
- WDQPAMHFFCXSNU-BGABXYSRSA-N clofazimine Chemical compound C12=CC=CC=C2N=C2C=C(NC=3C=CC(Cl)=CC=3)C(=N/C(C)C)/C=C2N1C1=CC=C(Cl)C=C1 WDQPAMHFFCXSNU-BGABXYSRSA-N 0.000 description 1
- 229940047766 co-trimoxazole Drugs 0.000 description 1
- 238000004891 communication Methods 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 238000004590 computer program Methods 0.000 description 1
- 239000002322 conducting polymer Substances 0.000 description 1
- 229920001940 conductive polymer Polymers 0.000 description 1
- 238000012790 confirmation Methods 0.000 description 1
- 238000002508 contact lithography Methods 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 230000008602 contraction Effects 0.000 description 1
- 239000002872 contrast media Substances 0.000 description 1
- 229920001577 copolymer Polymers 0.000 description 1
- 230000002596 correlated effect Effects 0.000 description 1
- 238000005859 coupling reaction Methods 0.000 description 1
- 235000018417 cysteine Nutrition 0.000 description 1
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 1
- 229960002806 daclizumab Drugs 0.000 description 1
- 229960000860 dapsone Drugs 0.000 description 1
- 230000007123 defense Effects 0.000 description 1
- 108010042194 dextransucrase Proteins 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 150000001989 diazonium salts Chemical class 0.000 description 1
- 229960001585 dicloxacillin Drugs 0.000 description 1
- YFAGHNZHGGCZAX-JKIFEVAISA-N dicloxacillin Chemical compound N([C@@H]1C(N2[C@H](C(C)(C)S[C@@H]21)C(O)=O)=O)C(=O)C1=C(C)ON=C1C1=C(Cl)C=CC=C1Cl YFAGHNZHGGCZAX-JKIFEVAISA-N 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 125000000118 dimethyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 238000007599 discharging Methods 0.000 description 1
- 238000012377 drug delivery Methods 0.000 description 1
- 229960001776 edrecolomab Drugs 0.000 description 1
- 210000002889 endothelial cell Anatomy 0.000 description 1
- 229960002549 enoxacin Drugs 0.000 description 1
- IDYZIJYBMGIQMJ-UHFFFAOYSA-N enoxacin Chemical compound N1=C2N(CC)C=C(C(O)=O)C(=O)C2=CC(F)=C1N1CCNCC1 IDYZIJYBMGIQMJ-UHFFFAOYSA-N 0.000 description 1
- 210000002919 epithelial cell Anatomy 0.000 description 1
- 229960003276 erythromycin Drugs 0.000 description 1
- 229960000285 ethambutol Drugs 0.000 description 1
- 239000004744 fabric Substances 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 210000002950 fibroblast Anatomy 0.000 description 1
- 229940126864 fibroblast growth factor Drugs 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 229960004273 floxacillin Drugs 0.000 description 1
- GNBHRKFJIUUOQI-UHFFFAOYSA-N fluorescein Chemical compound O1C(=O)C2=CC=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 GNBHRKFJIUUOQI-UHFFFAOYSA-N 0.000 description 1
- YMDXZJFXQJVXBF-STHAYSLISA-N fosfomycin Chemical compound C[C@@H]1O[C@@H]1P(O)(O)=O YMDXZJFXQJVXBF-STHAYSLISA-N 0.000 description 1
- VZCYOOQTPOCHFL-OWOJBTEDSA-L fumarate(2-) Chemical compound [O-]C(=O)\C=C\C([O-])=O VZCYOOQTPOCHFL-OWOJBTEDSA-L 0.000 description 1
- IECPWNUMDGFDKC-MZJAQBGESA-M fusidate Chemical compound O[C@@H]([C@@H]12)C[C@H]3\C(=C(/CCC=C(C)C)C([O-])=O)[C@@H](OC(C)=O)C[C@]3(C)[C@@]2(C)CC[C@@H]2[C@]1(C)CC[C@@H](O)[C@H]2C IECPWNUMDGFDKC-MZJAQBGESA-M 0.000 description 1
- 229960004675 fusidic acid Drugs 0.000 description 1
- 229960003923 gatifloxacin Drugs 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 238000001879 gelation Methods 0.000 description 1
- 238000010353 genetic engineering Methods 0.000 description 1
- 229940116332 glucose oxidase Drugs 0.000 description 1
- 235000019420 glucose oxidase Nutrition 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- 210000002149 gonad Anatomy 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 229910052736 halogen Inorganic materials 0.000 description 1
- 150000002367 halogens Chemical class 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 229940022353 herceptin Drugs 0.000 description 1
- 229920006253 high performance fiber Polymers 0.000 description 1
- 239000003667 hormone antagonist Substances 0.000 description 1
- 229920002674 hyaluronan Polymers 0.000 description 1
- 229960003160 hyaluronic acid Drugs 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 210000003016 hypothalamus Anatomy 0.000 description 1
- 229960001001 ibritumomab tiuxetan Drugs 0.000 description 1
- 229950002200 igovomab Drugs 0.000 description 1
- 229950007354 imciromab Drugs 0.000 description 1
- 230000028993 immune response Effects 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 230000001976 improved effect Effects 0.000 description 1
- 238000011065 in-situ storage Methods 0.000 description 1
- 230000006698 induction Effects 0.000 description 1
- 229960000598 infliximab Drugs 0.000 description 1
- 230000010354 integration Effects 0.000 description 1
- 230000002452 interceptive effect Effects 0.000 description 1
- 239000013067 intermediate product Substances 0.000 description 1
- 230000031146 intracellular signal transduction Effects 0.000 description 1
- 229920000554 ionomer Polymers 0.000 description 1
- 210000004153 islets of langerhan Anatomy 0.000 description 1
- 229960003350 isoniazid Drugs 0.000 description 1
- QRXWMOHMRWLFEY-UHFFFAOYSA-N isoniazide Chemical compound NNC(=O)C1=CC=NC=C1 QRXWMOHMRWLFEY-UHFFFAOYSA-N 0.000 description 1
- 210000002510 keratinocyte Anatomy 0.000 description 1
- 238000007648 laser printing Methods 0.000 description 1
- 230000002045 lasting effect Effects 0.000 description 1
- OJMMVQQUTAEWLP-KIDUDLJLSA-N lincomycin Chemical compound CN1C[C@H](CCC)C[C@H]1C(=O)N[C@H]([C@@H](C)O)[C@@H]1[C@H](O)[C@H](O)[C@@H](O)[C@@H](SC)O1 OJMMVQQUTAEWLP-KIDUDLJLSA-N 0.000 description 1
- TYZROVQLWOKYKF-ZDUSSCGKSA-N linezolid Chemical compound O=C1O[C@@H](CNC(=O)C)CN1C(C=C1F)=CC=C1N1CCOCC1 TYZROVQLWOKYKF-ZDUSSCGKSA-N 0.000 description 1
- 229960003907 linezolid Drugs 0.000 description 1
- 235000019421 lipase Nutrition 0.000 description 1
- 239000003120 macrolide antibiotic agent Substances 0.000 description 1
- 210000004962 mammalian cell Anatomy 0.000 description 1
- 230000000873 masking effect Effects 0.000 description 1
- 210000001595 mastoid Anatomy 0.000 description 1
- 229960005108 mepolizumab Drugs 0.000 description 1
- 238000013508 migration Methods 0.000 description 1
- 230000005012 migration Effects 0.000 description 1
- 229960004023 minocycline Drugs 0.000 description 1
- 238000000324 molecular mechanic Methods 0.000 description 1
- 230000000921 morphogenic effect Effects 0.000 description 1
- 229960003128 mupirocin Drugs 0.000 description 1
- 229930187697 mupirocin Natural products 0.000 description 1
- DDHVILIIHBIMQU-YJGQQKNPSA-L mupirocin calcium hydrate Chemical compound O.O.[Ca+2].C[C@H](O)[C@H](C)[C@@H]1O[C@H]1C[C@@H]1[C@@H](O)[C@@H](O)[C@H](C\C(C)=C\C(=O)OCCCCCCCCC([O-])=O)OC1.C[C@H](O)[C@H](C)[C@@H]1O[C@H]1C[C@@H]1[C@@H](O)[C@@H](O)[C@H](C\C(C)=C\C(=O)OCCCCCCCCC([O-])=O)OC1 DDHVILIIHBIMQU-YJGQQKNPSA-L 0.000 description 1
- 238000001127 nanoimprint lithography Methods 0.000 description 1
- 239000002105 nanoparticle Substances 0.000 description 1
- 229960005027 natalizumab Drugs 0.000 description 1
- 239000003345 natural gas Substances 0.000 description 1
- 229960004927 neomycin Drugs 0.000 description 1
- 229940053128 nerve growth factor Drugs 0.000 description 1
- 210000002569 neuron Anatomy 0.000 description 1
- 239000002858 neurotransmitter agent Substances 0.000 description 1
- 235000001968 nicotinic acid Nutrition 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 239000000615 nonconductor Substances 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 229960001699 ofloxacin Drugs 0.000 description 1
- 229960000470 omalizumab Drugs 0.000 description 1
- 229950007283 oregovomab Drugs 0.000 description 1
- 230000011164 ossification Effects 0.000 description 1
- 210000002997 osteoclast Anatomy 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- LSQZJLSUYDQPKJ-UHFFFAOYSA-N p-Hydroxyampicillin Natural products O=C1N2C(C(O)=O)C(C)(C)SC2C1NC(=O)C(N)C1=CC=C(O)C=C1 LSQZJLSUYDQPKJ-UHFFFAOYSA-N 0.000 description 1
- 238000004806 packaging method and process Methods 0.000 description 1
- 238000012856 packing Methods 0.000 description 1
- 238000010422 painting Methods 0.000 description 1
- 229960000402 palivizumab Drugs 0.000 description 1
- 229940049954 penicillin Drugs 0.000 description 1
- 230000000737 periodic effect Effects 0.000 description 1
- 108040007629 peroxidase activity proteins Proteins 0.000 description 1
- 239000008177 pharmaceutical agent Substances 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 239000004038 photonic crystal Substances 0.000 description 1
- 230000035479 physiological effects, processes and functions Effects 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 210000000280 pituicyte Anatomy 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 239000002985 plastic film Substances 0.000 description 1
- 229920006255 plastic film Polymers 0.000 description 1
- 239000004584 polyacrylic acid Substances 0.000 description 1
- 108010054442 polyalanine Proteins 0.000 description 1
- 108010064470 polyaspartate Proteins 0.000 description 1
- 108010094020 polyglycine Proteins 0.000 description 1
- 239000004633 polyglycolic acid Substances 0.000 description 1
- 229920000656 polylysine Polymers 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 229920002223 polystyrene Polymers 0.000 description 1
- 229920001343 polytetrafluoroethylene Polymers 0.000 description 1
- 239000004810 polytetrafluoroethylene Substances 0.000 description 1
- 150000004032 porphyrins Chemical class 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 229960005206 pyrazinamide Drugs 0.000 description 1
- IPEHBUMCGVEMRF-UHFFFAOYSA-N pyrazinecarboxamide Chemical compound NC(=O)C1=CN=CC=N1 IPEHBUMCGVEMRF-UHFFFAOYSA-N 0.000 description 1
- 239000010453 quartz Substances 0.000 description 1
- LISFMEBWQUVKPJ-UHFFFAOYSA-N quinolin-2-ol Chemical compound C1=CC=C2NC(=O)C=CC2=C1 LISFMEBWQUVKPJ-UHFFFAOYSA-N 0.000 description 1
- WTHRRGMBUAHGNI-LCYNINFDSA-N quinupristin Chemical compound N([C@@H]1C(=O)N[C@@H](C(N2CCC[C@H]2C(=O)N(C)[C@@H](CC=2C=CC(=CC=2)N(C)C)C(=O)N2C[C@@H](CS[C@H]3C4CCN(CC4)C3)C(=O)C[C@H]2C(=O)N[C@H](C(=O)O[C@@H]1C)C=1C=CC=CC=1)=O)CC)C(=O)C1=NC=CC=C1O WTHRRGMBUAHGNI-LCYNINFDSA-N 0.000 description 1
- 229960005442 quinupristin Drugs 0.000 description 1
- 108700028429 quinupristin Proteins 0.000 description 1
- 229960003876 ranibizumab Drugs 0.000 description 1
- 239000000376 reactant Substances 0.000 description 1
- 230000036647 reaction Effects 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 239000005871 repellent Substances 0.000 description 1
- 238000012958 reprocessing Methods 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 230000006335 response to radiation Effects 0.000 description 1
- 108091008146 restriction endonucleases Proteins 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- ATEBXHFBFRCZMA-VXTBVIBXSA-N rifabutin Chemical compound O([C@](C1=O)(C)O/C=C/[C@@H]([C@H]([C@@H](OC(C)=O)[C@H](C)[C@H](O)[C@H](C)[C@@H](O)[C@@H](C)\C=C\C=C(C)/C(=O)NC(=C2N3)C(=O)C=4C(O)=C5C)C)OC)C5=C1C=4C2=NC13CCN(CC(C)C)CC1 ATEBXHFBFRCZMA-VXTBVIBXSA-N 0.000 description 1
- 229960000885 rifabutin Drugs 0.000 description 1
- 229960001225 rifampicin Drugs 0.000 description 1
- 229960004641 rituximab Drugs 0.000 description 1
- 229950005374 ruplizumab Drugs 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 238000004626 scanning electron microscopy Methods 0.000 description 1
- 238000007789 sealing Methods 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 238000002444 silanisation Methods 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N silicon dioxide Inorganic materials O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- 229920005573 silicon-containing polymer Polymers 0.000 description 1
- 238000004088 simulation Methods 0.000 description 1
- 210000002363 skeletal muscle cell Anatomy 0.000 description 1
- 210000000329 smooth muscle myocyte Anatomy 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 238000005507 spraying Methods 0.000 description 1
- 238000010561 standard procedure Methods 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 238000007619 statistical method Methods 0.000 description 1
- 210000000130 stem cell Anatomy 0.000 description 1
- 150000003431 steroids Chemical class 0.000 description 1
- 229950010708 sulesomab Drugs 0.000 description 1
- NCEXYHBECQHGNR-QZQOTICOSA-N sulfasalazine Chemical compound C1=C(O)C(C(=O)O)=CC(\N=N\C=2C=CC(=CC=2)S(=O)(=O)NC=2N=CC=CC=2)=C1 NCEXYHBECQHGNR-QZQOTICOSA-N 0.000 description 1
- 229960001940 sulfasalazine Drugs 0.000 description 1
- 238000006557 surface reaction Methods 0.000 description 1
- 239000003356 suture material Substances 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 239000013077 target material Substances 0.000 description 1
- 229910052713 technetium Inorganic materials 0.000 description 1
- GKLVYJBZJHMRIY-UHFFFAOYSA-N technetium atom Chemical compound [Tc] GKLVYJBZJHMRIY-UHFFFAOYSA-N 0.000 description 1
- 230000002381 testicular Effects 0.000 description 1
- 238000010257 thawing Methods 0.000 description 1
- 229960005267 tositumomab Drugs 0.000 description 1
- 231100000167 toxic agent Toxicity 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 210000000682 transitional epithelial cell Anatomy 0.000 description 1
- 238000013519 translation Methods 0.000 description 1
- GQIUQDDJKHLHTB-UHFFFAOYSA-N trichloro(ethenyl)silane Chemical compound Cl[Si](Cl)(Cl)C=C GQIUQDDJKHLHTB-UHFFFAOYSA-N 0.000 description 1
- ZDHXKXAHOVTTAH-UHFFFAOYSA-N trichlorosilane Chemical compound Cl[SiH](Cl)Cl ZDHXKXAHOVTTAH-UHFFFAOYSA-N 0.000 description 1
- 239000005052 trichlorosilane Substances 0.000 description 1
- QQQSFSZALRVCSZ-UHFFFAOYSA-N triethoxysilane Chemical compound CCO[SiH](OCC)OCC QQQSFSZALRVCSZ-UHFFFAOYSA-N 0.000 description 1
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 1
- 238000011144 upstream manufacturing Methods 0.000 description 1
- MYPYJXKWCTUITO-LYRMYLQWSA-N vancomycin Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=C2C=C3C=C1OC1=CC=C(C=C1Cl)[C@@H](O)[C@H](C(N[C@@H](CC(N)=O)C(=O)N[C@H]3C(=O)N[C@H]1C(=O)N[C@H](C(N[C@@H](C3=CC(O)=CC(O)=C3C=3C(O)=CC=C1C=3)C(O)=O)=O)[C@H](O)C1=CC=C(C(=C1)Cl)O2)=O)NC(=O)[C@@H](CC(C)C)NC)[C@H]1C[C@](C)(N)[C@H](O)[C@H](C)O1 MYPYJXKWCTUITO-LYRMYLQWSA-N 0.000 description 1
- 229960003165 vancomycin Drugs 0.000 description 1
- MYPYJXKWCTUITO-UHFFFAOYSA-N vancomycin Natural products O1C(C(=C2)Cl)=CC=C2C(O)C(C(NC(C2=CC(O)=CC(O)=C2C=2C(O)=CC=C3C=2)C(O)=O)=O)NC(=O)C3NC(=O)C2NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(CC(C)C)NC)C(O)C(C=C3Cl)=CC=C3OC3=CC2=CC1=C3OC1OC(CO)C(O)C(O)C1OC1CC(C)(N)C(O)C(C)O1 MYPYJXKWCTUITO-UHFFFAOYSA-N 0.000 description 1
- 239000005050 vinyl trichlorosilane Substances 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 229950003511 votumumab Drugs 0.000 description 1
- 210000004885 white matter Anatomy 0.000 description 1
Images
Classifications
-
- H—ELECTRICITY
- H05—ELECTRIC TECHNIQUES NOT OTHERWISE PROVIDED FOR
- H05K—PRINTED CIRCUITS; CASINGS OR CONSTRUCTIONAL DETAILS OF ELECTRIC APPARATUS; MANUFACTURE OF ASSEMBLAGES OF ELECTRICAL COMPONENTS
- H05K1/00—Printed circuits
- H05K1/02—Details
- H05K1/03—Use of materials for the substrate
- H05K1/0313—Organic insulating material
- H05K1/032—Organic insulating material consisting of one material
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/17—Systems in which incident light is modified in accordance with the properties of the material investigated
- G01N21/25—Colour; Spectral properties, i.e. comparison of effect of material on the light at two or more different wavelengths or wavelength bands
- G01N21/31—Investigating relative effect of material at wavelengths characteristic of specific elements or molecules, e.g. atomic absorption spectrometry
- G01N21/35—Investigating relative effect of material at wavelengths characteristic of specific elements or molecules, e.g. atomic absorption spectrometry using infrared light
- G01N21/3581—Investigating relative effect of material at wavelengths characteristic of specific elements or molecules, e.g. atomic absorption spectrometry using infrared light using far infrared light; using Terahertz radiation
- G01N21/3586—Investigating relative effect of material at wavelengths characteristic of specific elements or molecules, e.g. atomic absorption spectrometry using infrared light using far infrared light; using Terahertz radiation by Terahertz time domain spectroscopy [THz-TDS]
-
- H—ELECTRICITY
- H01—ELECTRIC ELEMENTS
- H01Q—ANTENNAS, i.e. RADIO AERIALS
- H01Q7/00—Loop antennas with a substantially uniform current distribution around the loop and having a directional radiation pattern in a plane perpendicular to the plane of the loop
-
- G—PHYSICS
- G02—OPTICS
- G02B—OPTICAL ELEMENTS, SYSTEMS OR APPARATUS
- G02B1/00—Optical elements characterised by the material of which they are made; Optical coatings for optical elements
- G02B1/002—Optical elements characterised by the material of which they are made; Optical coatings for optical elements made of materials engineered to provide properties not available in nature, e.g. metamaterials
Landscapes
- Physics & Mathematics (AREA)
- Spectroscopy & Molecular Physics (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Microelectronics & Electronic Packaging (AREA)
- General Health & Medical Sciences (AREA)
- Immunology (AREA)
- Chemical & Material Sciences (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- Toxicology (AREA)
- General Physics & Mathematics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pathology (AREA)
- Peptides Or Proteins (AREA)
- Materials For Medical Uses (AREA)
- Aerials With Secondary Devices (AREA)
- Details Of Aerials (AREA)
- Support Of Aerials (AREA)
- Application Of Or Painting With Fluid Materials (AREA)
- Control Of Motors That Do Not Use Commutators (AREA)
Abstract
Description
Claims (28)
Applications Claiming Priority (7)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US32317210P | 2010-04-12 | 2010-04-12 | |
US61/323,172 | 2010-04-12 | ||
US32559310P | 2010-04-19 | 2010-04-19 | |
US61/325,593 | 2010-04-19 | ||
US201161446158P | 2011-02-24 | 2011-02-24 | |
US61/446,158 | 2011-02-24 | ||
PCT/US2011/032195 WO2011130335A2 (en) | 2010-04-12 | 2011-04-12 | Silk electronic components |
Publications (1)
Publication Number | Publication Date |
---|---|
CN103181025A true CN103181025A (zh) | 2013-06-26 |
Family
ID=44799284
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2011800288738A Pending CN103181025A (zh) | 2010-04-12 | 2011-04-12 | 丝电子部件 |
Country Status (6)
Country | Link |
---|---|
US (1) | US9603243B2 (zh) |
EP (1) | EP2559101B1 (zh) |
JP (1) | JP2013533754A (zh) |
CN (1) | CN103181025A (zh) |
CA (1) | CA2832795C (zh) |
WO (1) | WO2011130335A2 (zh) |
Cited By (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103715477A (zh) * | 2013-12-03 | 2014-04-09 | 西安交通大学 | 一种微波频段三频极化无关90度极化旋转器及其应用 |
CN103746191A (zh) * | 2014-01-08 | 2014-04-23 | 中电科技扬州宝军电子有限公司 | 超紧凑型超材料吸波单元 |
CN104764711A (zh) * | 2015-04-17 | 2015-07-08 | 中国科学院重庆绿色智能技术研究院 | 太赫兹超材料生物传感芯片及其测试方法 |
CN105006642A (zh) * | 2015-06-26 | 2015-10-28 | 桂林电子科技大学 | 单负材料隔离板及宽频高隔离度单极子阵列天线 |
KR20160146656A (ko) * | 2014-02-26 | 2016-12-21 | 메디칼 와이어리스 센싱 엘티디 | 센서 |
CN106469855A (zh) * | 2015-08-20 | 2017-03-01 | 深圳光启高等理工研究院 | 太赫兹超材料 |
CN108336505A (zh) * | 2018-01-31 | 2018-07-27 | 电子科技大学 | 一种太赫兹波段宽带极化不敏感超材料 |
CN108777367A (zh) * | 2018-05-29 | 2018-11-09 | 南京理工大学 | 一种x波段极化不敏感电磁伪装超表面阵列 |
CN109171671A (zh) * | 2018-06-26 | 2019-01-11 | 浙江大学 | 一种基于极化转换超表面的生命体征检测方法 |
CN109935972A (zh) * | 2019-01-25 | 2019-06-25 | 南通大学 | 一种基于等离子体激元的宽带天线 |
CN110941139A (zh) * | 2019-12-02 | 2020-03-31 | 中国科学院上海微系统与信息技术研究所 | 一种生物蛋白膜表面图案化制作方法 |
CN111938632A (zh) * | 2020-08-10 | 2020-11-17 | 中国科学院上海微系统与信息技术研究所 | 一种脑内信号采集器件及其制备方法、脑机接口 |
CN112002967A (zh) * | 2020-07-20 | 2020-11-27 | 重庆邮电大学 | 一种“背对称开口方槽”型的太赫兹低通角度滤波器 |
CN112467319A (zh) * | 2020-12-15 | 2021-03-09 | 郑州中科集成电路与信息系统产业创新研究院 | 一种太赫兹滤波器 |
CN113224543A (zh) * | 2021-04-25 | 2021-08-06 | 中国人民解放军空军工程大学 | 一种可见光-红外-微波三频段兼容的超表面 |
CN113381200A (zh) * | 2021-05-13 | 2021-09-10 | 宁波大学 | 一种宽入射角度的电磁吸收结构 |
CN113424290A (zh) * | 2019-02-13 | 2021-09-21 | Asml荷兰有限公司 | 控制带电粒子束的能量散布的装置和方法 |
CN113745778A (zh) * | 2021-09-03 | 2021-12-03 | 合肥工业大学 | 一种双频段极化敏感带阻滤波器及其制备方法 |
Families Citing this family (55)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ATE526378T1 (de) | 2005-08-02 | 2011-10-15 | Tufts College | Verfahren zur stufenweisen ablagerung von seidenfibroinbeschichtungen |
EP2974673B1 (en) | 2010-03-17 | 2017-03-22 | The Board of Trustees of the University of Illionis | Implantable biomedical devices on bioresorbable substrates |
WO2012031282A2 (en) * | 2010-09-03 | 2012-03-08 | Tufts University/Trustees Of Tufts College | Plasmonic nanoparticle-doped silk materials |
US9459375B2 (en) * | 2010-11-05 | 2016-10-04 | Tufts University | Active manipulation of electromagnetic wave propagation in metamaterials |
JP5786372B2 (ja) * | 2011-03-03 | 2015-09-30 | 大日本印刷株式会社 | ポリジメチルシロキサンシートとこれを使用した光学素子およびこれらの製造方法 |
CN102522320B (zh) * | 2011-11-11 | 2014-05-07 | 南京邮电大学 | 一种生物模板排列纳米线的方法 |
EP2767632B1 (en) * | 2011-11-17 | 2019-05-29 | Nippon Telegraph and Telephone Corporation | Conductive polymer fibers, biological electrode and implantable electrode |
KR101979354B1 (ko) * | 2011-12-01 | 2019-08-29 | 더 보오드 오브 트러스티스 오브 더 유니버시티 오브 일리노이즈 | 프로그램 변형을 실행하도록 설계된 과도 장치 |
US10126467B2 (en) | 2011-12-05 | 2018-11-13 | Tufts University | Signal enhancement by silk photonic crystals |
GB2500719B (en) | 2012-03-30 | 2017-05-31 | Medical Wireless Sensing Ltd | Coupling electromagnetic radiation into a target |
CN102723604B (zh) * | 2012-05-30 | 2015-04-15 | 深圳光启创新技术有限公司 | 一种喇叭天线 |
CN102769189B (zh) * | 2012-06-29 | 2015-12-16 | 深圳光启创新技术有限公司 | 一种喇叭透镜天线 |
US9000376B2 (en) | 2012-07-03 | 2015-04-07 | Massachusettes Institute Of Technology | Detection of electromagnetic radiation using nonlinear materials |
CN102820512B (zh) * | 2012-08-30 | 2015-02-18 | 中国科学院上海微系统与信息技术研究所 | 可用于实现太赫兹特异介质的电磁谐振单元结构及方法 |
RU2511070C1 (ru) * | 2012-10-01 | 2014-04-10 | Общество с ограниченной ответственностью "ТИДЕКС" | Устройство визуализации источников терагерцового излучения |
WO2014085725A1 (en) | 2012-11-27 | 2014-06-05 | Tufts University | Biopolymer-based inks and use thereof |
WO2014127309A1 (en) | 2013-02-15 | 2014-08-21 | Tufts University | Silk-based nanoimprinting |
US11009792B2 (en) | 2013-03-15 | 2021-05-18 | Tufts University | All water-based nanopatterning |
CA3172969A1 (en) | 2013-03-15 | 2014-09-18 | Trustees Of Tufts College | Low molecular weight silk compositions and stabilizing silk compositions |
US11376329B2 (en) | 2013-03-15 | 2022-07-05 | Trustees Of Tufts College | Low molecular weight silk compositions and stabilizing silk compositions |
US10464361B2 (en) | 2013-03-15 | 2019-11-05 | Tufts University | Silk water lithography |
PL3049122T3 (pl) * | 2013-09-29 | 2018-07-31 | Universität Zürich | Elektrochemicznie modyfikowana powierzchnia struktur polimeru, szczególnie hydrożeli peg, dla wzmocnionej penetracji komórkowej |
CN106029176B (zh) * | 2013-09-30 | 2021-03-12 | 自然进化公司 | 丝蛋白片段组合物及从其生产的制品 |
US10513802B2 (en) | 2013-11-08 | 2019-12-24 | Tufts University | Peptide-based nanofibrillar materials |
EP2896717A1 (en) | 2014-01-15 | 2015-07-22 | Nanotechplasma SARL | Laser direct synthesis and deposit of nanocomposite materials or nanostructures |
WO2015134865A1 (en) | 2014-03-07 | 2015-09-11 | Tufts University | Biopolymer-based preservation of perishable products |
KR101629204B1 (ko) * | 2014-08-19 | 2016-06-10 | 전북대학교산학협력단 | 초박막 실크피브로인/콜라겐 복합이식체 및 이의 제조방법 |
GB201415681D0 (en) | 2014-09-04 | 2014-10-22 | Cambridge Entpr Ltd And President And Fellows Of Harvard College | Protien Capsules |
CN104434388B (zh) * | 2014-11-25 | 2017-05-24 | 陶虎 | 一种用于术后抑菌的可植入式电子加热模块及其制备方法 |
AU2015358537B2 (en) | 2014-12-02 | 2021-08-19 | Evolved By Nature, Inc. | Silk performance apparel and products and methods of preparing the same |
JP2016143921A (ja) * | 2015-01-29 | 2016-08-08 | 国立大学法人茨城大学 | シート型メタマテリアル |
JP2016158168A (ja) * | 2015-02-25 | 2016-09-01 | 国立大学法人茨城大学 | 偏波変換器 |
US10128387B1 (en) * | 2015-06-19 | 2018-11-13 | National Technology & Engineering Solutions Of Sandia, Llc | Optoelectronic apparatus enabled by dielectric metamaterials |
WO2017011679A1 (en) | 2015-07-14 | 2017-01-19 | Silk Therapeutics, Inc. | Silk performance apparel and products and methods of preparing the same |
CN104977272B (zh) * | 2015-07-17 | 2017-11-07 | 浙江大学 | 太赫兹超材料与纳米金颗粒联用的生物样品信号放大方法 |
US10925543B2 (en) | 2015-11-11 | 2021-02-23 | The Board Of Trustees Of The University Of Illinois | Bioresorbable silicon electronics for transient implants |
CN105610410B (zh) * | 2015-12-21 | 2018-04-06 | 电子科技大学 | 一种基于高电子迁移率晶体管的太赫兹多频带调制器 |
WO2017111752A1 (en) | 2015-12-22 | 2017-06-29 | Ozyegin Universitesi | Lighting interlayers for optical paths of light emitting or absorbing systems |
US11248313B2 (en) | 2016-08-01 | 2022-02-15 | Trustees Of Tufts College | Biomimetic mechanical tension driven fabrication of nanofibrillar architecture |
US11247181B2 (en) | 2016-10-24 | 2022-02-15 | Trustees Of Tufts College | Biomimetic multilayer compositions |
KR101887282B1 (ko) * | 2016-12-07 | 2018-08-09 | 서울대학교산학협력단 | 바이오 히터 |
WO2018236202A1 (fr) * | 2017-04-28 | 2018-12-27 | Emsi Rabat | Dispositif de protection du corps humain et des équipements contre le rayonnement électromagnétique |
US10655024B2 (en) | 2017-06-09 | 2020-05-19 | Virginia Commonwealth University | Flexible, biodegradable, and biocompatible supercapacitors |
US11390988B2 (en) | 2017-09-27 | 2022-07-19 | Evolved By Nature, Inc. | Silk coated fabrics and products and methods of preparing the same |
KR101943262B1 (ko) * | 2017-10-25 | 2019-01-28 | 한국과학기술원 | 실크 피브로인과 호환되는 하드 마스크와 이의 식각액을 이용한 패터닝 방법 |
JP7125261B2 (ja) * | 2017-12-12 | 2022-08-24 | 小島プレス工業株式会社 | 車両用撮影装置 |
IL256411A (en) | 2017-12-19 | 2018-01-31 | Univ Ramot | Method and system for controlling radiation scattering |
US11782013B2 (en) | 2018-08-08 | 2023-10-10 | University Of Central Florida Research Foundation, Inc. | Sensor device with biopolymer-metal composite film and related methods |
CN112928484B (zh) * | 2021-01-26 | 2022-03-25 | 南京航空航天大学 | 可动态调控散射性能的低rcs编码超表面天线及其设计方法 |
CN113097735B (zh) * | 2021-04-06 | 2022-03-18 | 南京大学 | 一种多功能超表面及隐身天线 |
CN113206388B (zh) * | 2021-05-13 | 2022-06-21 | 浙江大学 | 基于相位调制有源频率选择表面的成像系统及其成像方法 |
CN113437531B (zh) * | 2021-05-20 | 2022-07-12 | 西安电子科技大学 | 一种超小型化的角度不敏感的超材料吸波器 |
CN113451781B (zh) * | 2021-05-28 | 2022-07-08 | 西安电子科技大学 | 一种超小型化的2.5维吸透一体化频选吸波器 |
CN115204204B (zh) * | 2022-09-19 | 2022-12-02 | 江苏省质量和标准化研究院 | 基于mt-bp电磁感知的uhf多标签自适应识读方法及系统 |
US20240104583A1 (en) | 2022-09-26 | 2024-03-28 | Massachusetts Institute Of Technology | Integrating Biopolymer Design with Physical Unclonable Functions for Anticounterfeiting and Product Traceability |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1329721A (zh) * | 1998-12-02 | 2002-01-02 | 佛姆法克特股份有限公司 | 光刻接触元件 |
CN2870195Y (zh) * | 2005-08-19 | 2007-02-14 | 李宏强 | 一种频率选择装置 |
WO2008118211A2 (en) * | 2006-11-03 | 2008-10-02 | Trustees Of Tufts College | Biopolymer photonic crystals and method of manufacturing the same |
WO2009061823A1 (en) * | 2007-11-05 | 2009-05-14 | Trustees Of Tufts College | Fabrication of silk fibroin photonic structures by nanocontact imprinting |
Family Cites Families (30)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2575152A (en) * | 1950-09-06 | 1951-11-13 | Thomas C Whitner | Process of dissolving silk fibers |
US5245012A (en) | 1990-04-19 | 1993-09-14 | The United States Of America As Represented By The Secretary Of The Army | Method to achieve solubilization of spider silk proteins |
WO1997008315A1 (en) | 1995-08-22 | 1997-03-06 | Basel Richard M | Cloning methods for high strength spider silk proteins |
JP2005513162A (ja) | 2001-10-02 | 2005-05-12 | トラスティーズ オブ タフツ カレッジ | 自己集合性ポリマ及びそれから作製される材料 |
US6902932B2 (en) | 2001-11-16 | 2005-06-07 | Tissue Regeneration, Inc. | Helically organized silk fibroin fiber bundles for matrices in tissue engineering |
CN101820741A (zh) * | 2001-12-14 | 2010-09-01 | 莱尔德技术公司 | 包括有损耗的介质的电磁干扰屏蔽件 |
EP3351376B1 (en) | 2002-06-24 | 2023-04-12 | Tufts University | Silk biomaterials and methods of use thereof |
DE10229168A1 (de) * | 2002-06-28 | 2004-01-29 | Infineon Technologies Ag | Laminat mit einer als Antennenstruktur ausgebildeten elektrisch leitfähigen Schicht |
US7842780B2 (en) | 2003-01-07 | 2010-11-30 | Trustees Of Tufts College | Silk fibroin materials and use thereof |
JP4815554B2 (ja) | 2003-03-11 | 2011-11-16 | アラーガン、インコーポレイテッド | 免疫中立性の絹繊維を基礎とする医療用具 |
JP4698596B2 (ja) | 2003-04-10 | 2011-06-08 | タフツ ユニバーシティー | 濃縮された水性シルクフィブロイン溶液およびそれらの使用 |
WO2005000483A1 (en) | 2003-06-06 | 2005-01-06 | Tufts University | Method for forming inorganic coatings |
GB0401825D0 (en) * | 2003-12-05 | 2004-03-03 | Conductive Inkjet Tech Ltd | Formation of solid layers on substrates |
CA2608862C (en) | 2004-06-11 | 2020-05-05 | Trustees Of Tufts College | Silk-based drug delivery system |
JP4463645B2 (ja) | 2004-08-27 | 2010-05-19 | 日本メクトロン株式会社 | プリント基板およびその検査方法 |
US20090051071A1 (en) | 2005-03-25 | 2009-02-26 | National Institute Of Agrobiological Sciences | Dielectric substance and method of producing the same |
CA2611620A1 (en) | 2005-06-09 | 2006-12-21 | Lester E. Burgess | Hybrid conductive coating method for electrical bridging connection of rfid die chip to composite antenna |
ATE526378T1 (de) | 2005-08-02 | 2011-10-15 | Tufts College | Verfahren zur stufenweisen ablagerung von seidenfibroinbeschichtungen |
TWI654770B (zh) | 2006-09-06 | 2019-03-21 | 美國伊利諾大學理事會 | 二維可延伸且可撓曲設備及其製造方法 |
WO2008118133A2 (en) | 2006-09-26 | 2008-10-02 | Trustees Of Tufts College | Silk microspheres for encapsulation and controlled release |
WO2008121159A2 (en) | 2006-10-19 | 2008-10-09 | Los Alamos National Security Llc | Active terahertz metamaterial devices |
CA2704309C (en) | 2006-11-03 | 2017-02-28 | Trustees Of Tufts College | Electroactive biopolymer optical and electro-optical devices and method of manufacturing the same |
WO2008127402A2 (en) | 2006-11-03 | 2008-10-23 | Trustees Of Tufts College | Biopolymer sensor and method of manufacturing the same |
US7645326B2 (en) * | 2007-02-08 | 2010-01-12 | James Neil Rodgers | RFID environmental manipulation |
EP2152149A4 (en) | 2007-05-04 | 2013-05-15 | Univ Arizona | SYSTEM AND METHOD FOR THE WIRELESS TRANSMISSION OF BIOPOTICIALS |
AU2008260156B2 (en) | 2007-05-29 | 2013-10-31 | Trustees Of Tufts College | Method for silk fibroin gelation using sonication |
US8206774B2 (en) | 2008-03-13 | 2012-06-26 | Trustees Of Tufts College | Diazonium salt modification of silk polymer |
WO2010057142A2 (en) | 2008-11-17 | 2010-05-20 | Trustees Of Tufts College | Surface modification of silk fibroin matrices with poly(ethylene glycol) useful as anti adhesion barriers and anti thrombotic materials |
EP2974673B1 (en) | 2010-03-17 | 2017-03-22 | The Board of Trustees of the University of Illionis | Implantable biomedical devices on bioresorbable substrates |
US8129716B2 (en) | 2010-03-18 | 2012-03-06 | National Tsing Hua University | OTFT and MIM capacitor using silk protein as dielectric material and methods for manufacturing the same |
-
2011
- 2011-04-12 CA CA2832795A patent/CA2832795C/en active Active
- 2011-04-12 EP EP11769485.1A patent/EP2559101B1/en active Active
- 2011-04-12 CN CN2011800288738A patent/CN103181025A/zh active Pending
- 2011-04-12 US US13/641,000 patent/US9603243B2/en active Active
- 2011-04-12 WO PCT/US2011/032195 patent/WO2011130335A2/en active Application Filing
- 2011-04-12 JP JP2013505073A patent/JP2013533754A/ja active Pending
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1329721A (zh) * | 1998-12-02 | 2002-01-02 | 佛姆法克特股份有限公司 | 光刻接触元件 |
CN2870195Y (zh) * | 2005-08-19 | 2007-02-14 | 李宏强 | 一种频率选择装置 |
WO2008118211A2 (en) * | 2006-11-03 | 2008-10-02 | Trustees Of Tufts College | Biopolymer photonic crystals and method of manufacturing the same |
WO2009061823A1 (en) * | 2007-11-05 | 2009-05-14 | Trustees Of Tufts College | Fabrication of silk fibroin photonic structures by nanocontact imprinting |
Cited By (26)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103715477A (zh) * | 2013-12-03 | 2014-04-09 | 西安交通大学 | 一种微波频段三频极化无关90度极化旋转器及其应用 |
CN103746191A (zh) * | 2014-01-08 | 2014-04-23 | 中电科技扬州宝军电子有限公司 | 超紧凑型超材料吸波单元 |
KR20160146656A (ko) * | 2014-02-26 | 2016-12-21 | 메디칼 와이어리스 센싱 엘티디 | 센서 |
KR102477156B1 (ko) * | 2014-02-26 | 2022-12-12 | 메디칼 와이어리스 센싱 엘티디 | 센서 |
CN104764711A (zh) * | 2015-04-17 | 2015-07-08 | 中国科学院重庆绿色智能技术研究院 | 太赫兹超材料生物传感芯片及其测试方法 |
CN104764711B (zh) * | 2015-04-17 | 2018-02-06 | 中国科学院重庆绿色智能技术研究院 | 太赫兹超材料生物传感芯片及其测试方法 |
CN105006642A (zh) * | 2015-06-26 | 2015-10-28 | 桂林电子科技大学 | 单负材料隔离板及宽频高隔离度单极子阵列天线 |
CN106469855A (zh) * | 2015-08-20 | 2017-03-01 | 深圳光启高等理工研究院 | 太赫兹超材料 |
CN106469855B (zh) * | 2015-08-20 | 2021-01-15 | 深圳光启高等理工研究院 | 太赫兹超材料 |
CN108336505B (zh) * | 2018-01-31 | 2020-07-28 | 电子科技大学 | 一种太赫兹波段宽带极化不敏感超材料 |
CN108336505A (zh) * | 2018-01-31 | 2018-07-27 | 电子科技大学 | 一种太赫兹波段宽带极化不敏感超材料 |
CN108777367A (zh) * | 2018-05-29 | 2018-11-09 | 南京理工大学 | 一种x波段极化不敏感电磁伪装超表面阵列 |
CN109171671A (zh) * | 2018-06-26 | 2019-01-11 | 浙江大学 | 一种基于极化转换超表面的生命体征检测方法 |
CN109935972B (zh) * | 2019-01-25 | 2021-01-26 | 南通大学 | 一种基于等离子体激元的宽带天线 |
CN109935972A (zh) * | 2019-01-25 | 2019-06-25 | 南通大学 | 一种基于等离子体激元的宽带天线 |
CN113424290A (zh) * | 2019-02-13 | 2021-09-21 | Asml荷兰有限公司 | 控制带电粒子束的能量散布的装置和方法 |
CN110941139A (zh) * | 2019-12-02 | 2020-03-31 | 中国科学院上海微系统与信息技术研究所 | 一种生物蛋白膜表面图案化制作方法 |
CN112002967A (zh) * | 2020-07-20 | 2020-11-27 | 重庆邮电大学 | 一种“背对称开口方槽”型的太赫兹低通角度滤波器 |
CN112002967B (zh) * | 2020-07-20 | 2021-09-10 | 重庆邮电大学 | 一种“背对称开口方槽”型的太赫兹低通角度滤波器 |
CN111938632A (zh) * | 2020-08-10 | 2020-11-17 | 中国科学院上海微系统与信息技术研究所 | 一种脑内信号采集器件及其制备方法、脑机接口 |
CN112467319A (zh) * | 2020-12-15 | 2021-03-09 | 郑州中科集成电路与信息系统产业创新研究院 | 一种太赫兹滤波器 |
CN113224543A (zh) * | 2021-04-25 | 2021-08-06 | 中国人民解放军空军工程大学 | 一种可见光-红外-微波三频段兼容的超表面 |
CN113381200B (zh) * | 2021-05-13 | 2022-07-15 | 宁波大学 | 一种宽入射角度的电磁吸收结构 |
CN113381200A (zh) * | 2021-05-13 | 2021-09-10 | 宁波大学 | 一种宽入射角度的电磁吸收结构 |
CN113745778A (zh) * | 2021-09-03 | 2021-12-03 | 合肥工业大学 | 一种双频段极化敏感带阻滤波器及其制备方法 |
CN113745778B (zh) * | 2021-09-03 | 2022-03-29 | 合肥工业大学 | 一种双频段极化敏感带阻滤波器的制备方法 |
Also Published As
Publication number | Publication date |
---|---|
EP2559101B1 (en) | 2016-02-24 |
US9603243B2 (en) | 2017-03-21 |
EP2559101A4 (en) | 2013-11-20 |
CA2832795A1 (en) | 2011-10-20 |
EP2559101A2 (en) | 2013-02-20 |
WO2011130335A3 (en) | 2011-12-29 |
CA2832795C (en) | 2018-01-09 |
US20130240251A1 (en) | 2013-09-19 |
WO2011130335A2 (en) | 2011-10-20 |
JP2013533754A (ja) | 2013-08-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103181025A (zh) | 丝电子部件 | |
Shi et al. | New silk road: from mesoscopic reconstruction/functionalization to flexible meso‐electronics/photonics based on cocoon silk materials | |
Tsioris et al. | Rapid transfer-based micro patterning and dry etching of silk microstructures | |
Tao et al. | Metamaterial silk composites at terahertz frequencies | |
Qu et al. | Flexible wearables for plants | |
Cohen-Karni et al. | Nanocomposite gold-silk nanofibers | |
Tao et al. | Silk materials–a road to sustainable high technology | |
Zhong et al. | Strong underwater adhesives made by self-assembling multi-protein nanofibres | |
Pereira et al. | Bombyx mori silk fibers: an outstanding family of materials | |
Lee et al. | A highly tunable and fully biocompatible silk nanoplasmonic optical sensor | |
Addison et al. | β-Sheet nanocrystalline domains formed from phosphorylated serine-rich motifs in caddisfly larval silk: a solid state NMR and XRD study | |
Borkner et al. | Coatings and films made of silk proteins | |
US9761789B2 (en) | Silk-based piezoelectric materials | |
JP2013538183A (ja) | 絹光学粒子およびその使用 | |
Eom et al. | Nanoarchitecturing of natural melanin nanospheres by layer-by-layer assembly: Macroscale anti-inflammatory conductive coatings with optoelectronic tunability | |
Patil et al. | Toward nontransient silk bioelectronics: engineering silk fibroin for bionic links | |
Zhang et al. | In situ mineralizing spinning of strong and tough silk fibers for optical waveguides | |
WO2018075125A2 (en) | Patterned silk inverse opal photonic crystals with tunable, geometrically defined structural color | |
Patil et al. | Green synthesis of gold nanoparticles: Its effect on cocoon and silk traits of mulberry silkworm (Bombyx mori L.) | |
Wang et al. | Robust, portable, and specific water-response silk film with noniridescent pattern encryption for information security | |
Kundu et al. | Biomimetic designing of functional silk nanotopography using self-assembly | |
Lin et al. | Patterned Duplex Fabric Based on Genetically Modified Spidroin for Smart Wound Management | |
Miao et al. | An Interfacial‐Assembled Self‐Supporting Nanofilm Induced by Strong Intermolecular Interaction between Silk Fibroin and Lysozyme | |
Melo et al. | Electrospun Collagen Scaffold Bio-Functionalized with Recombinant ICOS-Fc: An Advanced Approach to Promote Bone Remodelling | |
Lu et al. | Flexible Meso Electronics and Photonics Based on Cocoon Silk and Applications |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C53 | Correction of patent of invention or patent application | ||
CB03 | Change of inventor or designer information |
Inventor after: Kaplan David Inventor after: Omenetto Fiorenzo Inventor after: Tao Hu Inventor after: Averitt Richard Inventor after: Strikwerda Andrew Inventor after: Zhang Xin Inventor after: Tsioris Konstantinos Inventor before: Kaplan David Inventor before: Omenetto Fiorenzo Inventor before: Amsden Jason Inventor before: Tao Hu Inventor before: Averitt Richard Inventor before: Strikwerda Andrew Inventor before: Zhang Xin Inventor before: Tsioris Konstantinos |
|
COR | Change of bibliographic data |
Free format text: CORRECT: INVENTOR; FROM: KAPLAN DAVID OMENETTO FIORENZO AMSDEN JASON TAO HU AVERITT RICHARD STRIKWERDA ANDREW ZHANG XIN TSIORIS KONSTANTINOS TO: KAPLAN DAVID OMENETTO FIORENZO TAO HU AVERITT RICHARD STRIKWERDA ANDREW ZHANG XIN TSIORIS KONSTANTINOS |
|
C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20130626 |